GET THE APP
Paul A Lapchak Cedars-Sinai Medical Center, Los Angeles, Tanzania
Research Article Synergistic Effect of AJW200, a von Willebrand Factor Neutralizing Antibody with Low Dose (0.9 mg/mg) Thrombolytic Therapy Following Embolic Stroke in Rabbits Author(s):